ClariTrial | Search Clinical Trials

Explore/diabetes obesity metabolic disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

740 results for “diabetes obesity metabolic disease” · Recruiting

Page 1 of 50

Recruiting

Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being

N/AChronic DiseaseAdolescent AsthmaObesity & Overweight

Community Referral to Kaiona Programs

Waianae Coast Comprehensive Health Center100 participants1 site · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus

N/ADiabetes Mellitus, Type 2Diabetic Cardiomyopathies

Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopyTransthoracic echocardiographyComputed tomography coronary artery calcium scoring+5 more

University of Leicester593 participants1 site · United KingdomCompletes Oct 2029

Compare CT.gov Full analysis →

Recruiting

Optimal Digital Weight Loss Treatment for Rural Individuals

N/AOverweight and Obesity

CoreFacilitated Weekly Group SessionsCounselor Crafted Feedback+2 more

University of South Carolina616 participants1 site · United StatesCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

N/AObesityType2diabetesLipodystrophy

Mediterranean dietMelatonin supplementation

Federico II University100 participants4 sites · ItalyCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

Phase 2Metabolic-associated Fatty Liver Disease (MAFLD)

Combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabraPlacebo maltodextrin

Li Lab,MD100 participants2 sites · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Phase 1Healthy SubjectsObesityType 2 Diabetes

TLC-6740 Oral SolutionPlacebo Oral SolutionTLC-6740 Tablet+3 more

OrsoBio, Inc564 participants4 sites · New ZealandCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Thermogenenic Responses to Fasting and Overfeeding in Women

N/AObesity

Eucalaloric feedingAcute FastingAcute Overfeeding

University of Colorado, Denver56 participants1 site · United StatesCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes

N/AType 2 Diabetes

CH-rich diet with exerciseCH-reduced diet with exercise

Steno Diabetes Center Copenhagen24 participants1 site · DenmarkCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating

N/AHyperphagia

Neurofeedback with functional near infra-red spectroscopySham Neurofeedbackoral microbiota collection+4 more

Rennes University Hospital80 participants1 site · FranceCompletes May 2025

Compare CT.gov Full analysis →

Recruiting

Social Determinants of Sleep and Obesity

Early Phase 1Insufficient SleepPhysical InactivitySedentary Behavior

Sleep interventionContact Control

University of Minnesota90 participants1 site · United StatesCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Personalized Responses to Dietary Composition Trial 3

N/ADiabetesHeart DiseasesDiet Habit

Dietary Intervention

Zoe Global Limited250,000 participants2 sites · United States, United KingdomCompletes Jan 2030

Compare CT.gov Full analysis →

Recruiting

Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.

N/APolycystic Ovary SyndromeMetabolic Syndrome

Ovapro (Lifepro)

Celia Bañuls120 participants1 site · SpainCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Effects of SugarCut® Unripe Guava Fruit Extract on Blood Glucose Regulation

N/APreDiabetes

SugarCut® Unripe Guava Fruit ExtractPlacebo group

National Yang Ming Chiao Tung University60 participants1 site · TaiwanCompletes Jan 2025

Compare CT.gov Full analysis →

Recruiting

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Phase 2Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)

Empagliflozin (oral)Placebo

Abdelrahman Mahmoud66 participants1 site · EgyptCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Phase 1Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes

ALV-100Placebo

Alveus Therapeutics, Inc.180 participants1 site · United StatesCompletes Apr 2027

Compare CT.gov Full analysis →

1–15 of 740

Explore/diabetes obesity metabolic disease

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

740 results for “diabetes obesity metabolic disease” · Recruiting

Page 1 of 50

Recruiting

Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being

N/AChronic DiseaseAdolescent AsthmaObesity & Overweight

Community Referral to Kaiona Programs

Waianae Coast Comprehensive Health Center100 participants1 site · United StatesCompletes Aug 2028

Compare CT.gov Full analysis →

Recruiting

Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus

N/ADiabetes Mellitus, Type 2Diabetic Cardiomyopathies

Cardiovascular magnetic resonance (CMR) imaging and magnetic resonance spectroscopyTransthoracic echocardiographyComputed tomography coronary artery calcium scoring+5 more

University of Leicester593 participants1 site · United KingdomCompletes Oct 2029

Compare CT.gov Full analysis →

Recruiting

Optimal Digital Weight Loss Treatment for Rural Individuals

N/AOverweight and Obesity

CoreFacilitated Weekly Group SessionsCounselor Crafted Feedback+2 more

University of South Carolina616 participants1 site · United StatesCompletes Feb 2027

Compare CT.gov Full analysis →

Recruiting

Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"

N/AObesityType2diabetesLipodystrophy

Mediterranean dietMelatonin supplementation

Federico II University100 participants4 sites · ItalyCompletes Oct 2025

Compare CT.gov Full analysis →

Recruiting

Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial

Phase 2Metabolic-associated Fatty Liver Disease (MAFLD)

Combination of cynara scolymus, silybum marianum, curcuma longa, and glycyrrhiza glabraPlacebo maltodextrin

Li Lab,MD100 participants2 sites · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Phase 1Healthy SubjectsObesityType 2 Diabetes

TLC-6740 Oral SolutionPlacebo Oral SolutionTLC-6740 Tablet+3 more

OrsoBio, Inc564 participants4 sites · New ZealandCompletes Feb 2026

Compare CT.gov Full analysis →

Recruiting

Thermogenenic Responses to Fasting and Overfeeding in Women

N/AObesity

Eucalaloric feedingAcute FastingAcute Overfeeding

University of Colorado, Denver56 participants1 site · United StatesCompletes Dec 2029

Compare CT.gov Full analysis →

Recruiting

A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes

N/AType 2 Diabetes

CH-rich diet with exerciseCH-reduced diet with exercise

Steno Diabetes Center Copenhagen24 participants1 site · DenmarkCompletes Mar 2027

Compare CT.gov Full analysis →

Recruiting

fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating

N/AHyperphagia

Neurofeedback with functional near infra-red spectroscopySham Neurofeedbackoral microbiota collection+4 more

Rennes University Hospital80 participants1 site · FranceCompletes May 2025

Compare CT.gov Full analysis →

Recruiting

Social Determinants of Sleep and Obesity

Early Phase 1Insufficient SleepPhysical InactivitySedentary Behavior

Sleep interventionContact Control

University of Minnesota90 participants1 site · United StatesCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Personalized Responses to Dietary Composition Trial 3

N/ADiabetesHeart DiseasesDiet Habit

Dietary Intervention

Zoe Global Limited250,000 participants2 sites · United States, United KingdomCompletes Jan 2030

Compare CT.gov Full analysis →

Recruiting

Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.

N/APolycystic Ovary SyndromeMetabolic Syndrome

Ovapro (Lifepro)

Celia Bañuls120 participants1 site · SpainCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Effects of SugarCut® Unripe Guava Fruit Extract on Blood Glucose Regulation

N/APreDiabetes

SugarCut® Unripe Guava Fruit ExtractPlacebo group

National Yang Ming Chiao Tung University60 participants1 site · TaiwanCompletes Jan 2025

Compare CT.gov Full analysis →

Recruiting

Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy

Phase 2Metabolic SyndromeObesity & OverweightHIV (Human Immunodeficiency Virus)

Empagliflozin (oral)Placebo

Abdelrahman Mahmoud66 participants1 site · EgyptCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Phase 1Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes

ALV-100Placebo

Alveus Therapeutics, Inc.180 participants1 site · United StatesCompletes Apr 2027

Compare CT.gov Full analysis →

1–15 of 740